[1]
Tang, MSc, H. et al. 2017. Adverse Effects and Safety of SGLT2 Inhibitor Use among Patients with Type 2 Diabetes: Findings from RCT Evidence. North American Journal of Medicine and Science. 10, 2 (Apr. 2017).